This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI
by Zacks Equity Research
LLY, EPHE, BBC, HELX, XHS and SURI headline last week's top-performing ETFs as healthcare and biotech outperform a weak broader market.
Best-Performing ETFs of Last Week: Healthcare Rules
by Sanghamitra Saha
Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.
Invest in Emerging Asia in 2024 With These ETFs
by Yashwardhan Jain
With moderating inflation levels in most Asian countries and great growth potential in the medium to long term, investing in Emerging Asian countries can prove beneficial.
Tap Emerging Asia's Growth Potential With These ETFs
by Yashwardhan Jain
Emerging Asia countries can be great investment opportunities in the medium to long term. With rating agencies revising their 2024 growth projections for these countries upwards, look into how they stand to gain and what funds investors can invest in to gain exposure.
5 Winning ETFs of Last Week That Were Up At Least 2.9%
by Sanghamitra Saha
Wall Street was subdued last week due to the Fed's taper talks, the spread of the COVID-19 delta variant and China's persistent crackdown on its tech sector.
5 Top-Performing ETFs of Last Week
by Sanghamitra Saha
The S&P 500, the Dow Jones and the Nasdaq Composite lost about 0.5%, 1% and 1.1%, respectively, in the past week.
7 Top ETFs That Trumped Last Week's Market Rout
by Sanghamitra Saha
Last week was extremely volatile for Wall Street with the S&P 500, the Dow Jones and the Nasdaq losing about 2.5%, 1.7% and 4.1%, respectively.
Is it Time to Buy These ETFs on a Sudden Slowdown in EV Sales?
by Sanghamitra Saha
Global EV sales dropped for the first time in July. But the long-term prospects look bright. Is it the time to buy the slowdown in the EV market with these ETFs?
Philippines ETF Rebounds: Can the Rally Continue?
by Sanghamitra Saha
The stupendous rally in Philippine stocks on rate cut hopes puts the related ETF in focus.
Philippines Lags 2018 Growth Estimate: What Awaits EPHE?
by Zacks Equity Research
On an annual basis, Philippine's fourth-quarter GDP expanded at a 6.1% rate in comparison to the previous quarter's downwardly revised 6.0%, putting EPHE in focus.